Evidence map›Paper›PMID 32514584›Full record

ReviewVirchows Archiv : an international journal of pathology2021

Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses.

Melanie Bourgeau, Anthony P Martinez

Erratum issuedAbstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Melanie BourgeauDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.
Anthony P MartinezDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA. anthonymartinezmd@gmail.com.ORCID http://orcid.org/0000-0002-0815-3103
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histiocyte-rich rhabdomyoblastic tumor is a recently described skeletal muscle neoplasm of uncertain malignant potential, characterized by slow growth, a fibrous capsule containing peripheral lymphoid aggregates, spindle-to-epithelioid cells with a rhabdomyoblastic immunophenotype, and a dense histiocytic infiltrate. It most commonly arises within the muscles of the lower legs and trunk in young-to-middle-aged men, and initial reports suggest indolent behavior. In this paper, we present two additional cases of histiocyte-rich rhabdomyoblastic tumor with similar clinicopathologic features and discuss the differential diagnosis including its overlap with inflammatory leiomyosarcoma.

Indexed as

AdultBiomarkers, TumorBiopsy, Large-Core NeedleDiagnosis, DifferentialHistiocytesHumansImmunohistochemistryMaleMiddle AgedMuscle NeoplasmsPredictive Value of TestsRhabdomyomaBiomarkers, TumorHistiocyte-rich rhabdomyoblastic tumorInflammatory leiomyosarcomaMyoD1RhabdomyomaRhabdomyosarcomaSmooth muscle tumors

Identifiers

PMID32514584
OpenAlexW3033917125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.